| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9112057 | Diabetes Research and Clinical Practice | 2005 | 7 Pages |
Abstract
These results suggest that voglibose reduces the progression of IMT and may be a candidate for an anti-atherosclerotic drug for type 2 diabetic patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Yoshimitsu Yamasaki, Naoto Katakami, Rieko Hayaishi-Okano, Munehide Matsuhisa, Yoshitaka Kajimoto, Keisuke Kosugi, Mitue Hatano, Masatsugu Hori,